Renaissance Technologies (RenTech)'s SLS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 310,364 shares of SELLAS Life Sciences Group, Inc. (SLS) worth $4.58 M, representing 0.01% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in SLS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 310,364 shares. Largest reduction occurred in Q4 2025, reducing 291,822 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s SELLAS Life Sciences Group (SLS) Holding Value Over Time
Track share changes against reported price movement
Quarterly SELLAS Life Sciences Group (SLS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +310,364 | New Buy | 310,364 | $14.76 |
| Q4 2025 | -291,822 | Sold Out | 0 | $0.00 |
| Q3 2025 | +291,822 | New Buy | 291,822 | $1.61 |
| Q2 2025 | -34,892 | Sold Out | 0 | $0.00 |
| Q1 2025 | +34,892 | New Buy | 34,892 | $1.08 |
| Q4 2024 | -92,937 | Sold Out | 0 | $0.00 |
| Q3 2024 | +60,491 | Add 186.44% | 92,937 | $1.25 |
| Q2 2024 | +32,446 | New Buy | 32,446 | $1.19 |
| Q1 2024 | -50,400 | Sold Out | 0 | $0.00 |
| Q4 2023 | +50,400 | New Buy | 50,400 | $1.05 |
| Q4 2022 | -22,400 | Sold Out | 0 | $0.00 |
| Q3 2022 | -11,438 | Reduce 33.80% | 22,400 | $2.01 |
| Q2 2022 | +33,838 | New Buy | 33,838 | $2.22 |
| Q3 2020 | -14,360 | Sold Out | 0 | $0.00 |
| Q2 2020 | +14,360 | New Buy | 14,360 | $2.92 |
Renaissance Technologies (RenTech)'s SELLAS Life Sciences Group Investment FAQs
Renaissance Technologies (RenTech) first purchased SELLAS Life Sciences Group, Inc. (SLS) in Q2 2020, acquiring 14,360 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held SELLAS Life Sciences Group, Inc. (SLS) for 15 quarters since Q2 2020.
Renaissance Technologies (RenTech)'s largest addition to SELLAS Life Sciences Group, Inc. (SLS) was in Q2 2026, adding 310,364 shares worth $4.58 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 310,364 shares of SELLAS Life Sciences Group, Inc. (SLS), valued at approximately $4.58 M.
As of the Q2 2026 filing, SELLAS Life Sciences Group, Inc. (SLS) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in SELLAS Life Sciences Group, Inc. (SLS) was 310,364 shares, as reported at the end of Q2 2026.